Sharemaestro Newsreel

Guggenheim raises Neurocrine Bio stock price target on Ingrezza beat

Guggenheim has increased its price target for Neurocrine Biosciences Inc. (NASDAQ:NBIX) shares to $222 from $200, maintaining a Buy rating after the company's strong second-quarter results. The company reported Ingrezza sales significantly above consensus and raised its full-year 2026 Ingrezza sales guidance, driven by …

Haleon falls Friday, underperforms market

Haleon PLC (HLN) shares fell 1.44% to £3.63 on Friday, underperforming the broader market as the FTSE 100 Index also saw a decline. The company's stock closed 12.69% below its 52-week high of £4.16. This performance occurred on an overall dismal trading session for …

HALEON PLC To Go Ex-Dividend On August 13th, 2026 With 0.03226 USD Dividend Per Share

Haleon PLC (NYSE:HLN) is scheduled to go ex-dividend on August 13th, 2026, with a dividend payment of 0.03226 USD per share. This information is relevant for investors looking to receive the upcoming dividend.

Takeda Ready to Resume Top-Line Growth With Refreshed Late-Stage Pipeline

Takeda Pharmaceutical, Japan's leading pharmaceutical company, is poised for top-line growth driven by a refreshed late-stage pipeline. The company has strategically diversified away from the stagnant Japanese market through significant acquisitions, notably the $57 billion purchase of Shire Plc in 2019, which expanded its …

EBS|Emergent BioSolutions Inc|Price:7.220|Chg%:-0.050

This article provides a comprehensive stock analysis of Emergent BioSolutions Inc (EBS) by TradingKey, assigning it a "fairly valued" rating and a score of 6.62/10 in the Pharmaceuticals industry. The analysis highlights healthy fundamentals, high growth potential, and strong institutional ownership, despite a recent …

Prestige Consumer Number of Employees 2026 | Employee Count & Headcount Data

Prestige Consumer Healthcare, Inc. (PBH) had 897 employees worldwide as of March 2026, representing a 10.6% growth since 2023. The company is actively hiring, although job postings declined by 2.7% in 2026 compared to 2025. Its workforce is primarily concentrated in the United States, …

RBF Capital LLC Sells 30,000 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

RBF Capital LLC has reduced its stake in Teva Pharmaceutical Industries Ltd. by 60%, selling 30,000 shares and retaining 20,000 shares worth $602,000. This divestment occurred despite Teva reporting strong Q2 revenue of $4.14 billion, surpassing estimates, and raising its 2026 revenue outlook due …

[10-Q] NEUROCRINE BIOSCIENCES INC Quarterly Earnings Report

Neurocrine Biosciences Inc. (NBIX) filed its quarterly earnings report (Form 10-Q) with the SEC, detailing its financial performance for the quarter ended June 30, 2026. Key highlights include the completion of the Soleno Therapeutics Inc. acquisition, adding VYKAT XR to its commercial portfolio, and …

OMERS ADMINISTRATION Corp Makes New Investment in Kiniksa Pharmaceuticals International, plc $KNSA

OMERS ADMINISTRATION Corp reported a new investment in Kiniksa Pharmaceuticals International, plc, acquiring 13,100 shares valued at $631,000 during the first quarter. This increased institutional interest comes alongside several positive analyst price target revisions for KNSA, with an average target of $87.38 and primarily …

TherapeuticsMD Inc (TXMD) Financial Health: Profitability & Balance Sheet Analysis

The article provides a financial health analysis of TherapeuticsMD Inc (TXMD), noting its current financial score of 8.46, ranking 48th in the Pharmaceuticals industry. The company shows a stable financial status and high operating efficiency, with significant year-over-year increases in quarterly revenue (84.22%) and …

Cumberland Pharmaceuticals To Go Ex-Dividend On August 3rd, 2026 With 1.5 USD Special Dividend Per Share

Cumberland Pharmaceuticals (NASDAQ:CPIX) is set to go ex-dividend on August 3rd, 2026. The company will issue a special dividend of 1.5 USD per share. This information is crucial for investors interested in dividend capture strategies.

Biofrontera Inc (BFRI) Financial Health: Profitability & Balance Sheet Analysis

The article provides an analysis of Biofrontera Inc's financial health, indicating a stable financial status and high operating efficiency with a current financial score of 8.06. It highlights the company's latest quarterly revenue of $10.08 million, showing a 17.42% year-over-year increase, and a 13.06% …

IM Cannabis Corp (IMCC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of IM Cannabis Corp (IMCC), detailing its current price momentum score of 5.69 and noting its stock price is trading between support at $0.09 and resistance at $0.15. It includes a summary of various technical indicators (MACD, RSI, …

BioCryst Pharmaceuticals Inc (BCRX) Institutional Confidence

BioCryst Pharmaceuticals Inc (BCRX) has a high institutional shareholding score of 10.00, ranking 1st in its industry, despite a recent 10.51% quarter-over-quarter decrease in institutional shareholding proportion. The largest institutional shareholder is James Simons, and notable institutional holders include BlackRock, RA Capital Management, and …

Dimensional Fund Advisors LP Purchases 73,410 Shares of Teva Pharmaceutical Industries Ltd. $TEVA

Dimensional Fund Advisors LP increased its stake in Teva Pharmaceutical Industries Ltd. by 2.6%, acquiring an additional 73,410 shares and bringing its total holdings to 2.86 million shares valued at approximately $86.2 million. Institutional investors collectively own 54.05% of Teva, whose recent Q2 revenue …

Amneal Pharmaceuticals Inc (AMRX) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised ...

Arrowstreet Capital Limited Partnership Acquires 641,448 Shares of Elanco Animal Health Incorporated $ELAN

Arrowstreet Capital Limited Partnership significantly increased its stake in Elanco Animal Health Incorporated (NYSE:ELAN) by 310.0% in the first quarter, purchasing an additional 641,448 shares and bringing its total holdings to 848,372 shares valued at approximately $20.3 million. This move is part of broader …

Bausch Health Companies Inc. 2026: Revenue $2.85B, EPS $0.68— 10-Q Summary

Bausch Health Companies Inc. reported strong Q2 2026 results with revenue of $2.85 billion, an increase from $2.53 billion year-over-year. Diluted EPS rose to $0.68 from $0.40, and net income attributable to the company significantly increased to $258 million. This growth was driven by …

Akebia Therapeutics And 2 Promising Penny Stocks To Watch

This article identifies Akebia Therapeutics (AKBA), GoodRx Holdings (GDRX), and Snap (SNAP) as promising penny stocks to watch, despite their current unprofitability and financial challenges. It highlights their market caps, revenues, recent developments, and financial health, noting their potential for growth alongside inherent risks. …

Key facts: Haleon PLC ADR (HLN) H1 profit +8.2%; Iran war raises costs

Haleon PLC ADR (HLN) reported an 8.2% increase in H1 adjusted operating profit to £1.36bn, with adjusted EPS up 12% to 10.3p and an interim dividend of 2.4p. The company also completed a £457m buyback. Despite these gains, the Iran war is expected to …

Aytu Biopharma Inc (AYTU) Financial Health: Profitability & Balance Sheet Analysis

Aytu Biopharma Inc (AYTU) currently holds a financial score of 7.93, ranking 88 out of 155 in the Pharmaceuticals industry, indicating stable financial status and high operating efficiency. Despite this, its latest quarterly revenue decreased by 32.74% year-over-year, and net profit saw a significant …

Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for

Amphastar Pharmaceuticals (AMPH) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare …

BioAge Labs, Inc. (NASDAQ:BIOA) Short Interest Update

CTOR|Citius Oncology Inc|Price:0.654|Chg%:+0.062

Cronos Group Inc. (CRON) Stock Analysis: Assessing Potential Amid Robust Revenue Growth

Kiniksa Pharmaceuticals International, plc 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:KNSA) 2026-07-31

AMRX Down Despite Q2 Earnings Beat, 2026 Revenue Outlook Raised

Amneal Pharmaceuticals AMRX reported second-quarter 2026 adjusted earnings of 30 cents per share, which beat the Zacks Consensus Estimate of 24 cents. Earnings increased 20% year over year, driven by strong performance across the company's three business segments. Total revenues of $796 million in …

Alkermes plc 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ALKS) 2026-07-31

Alkermes plc Q2 2026 Earnings Call Summary - Moby Strategic Evolution and Operational Context Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. …

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Up 8.7% - Should You Buy?

Haleon (NYSE:HLN) Posts Quarterly Earnings Results, Misses Expectations By $0.13 EPS

Royal Bank of Canada Buys 434,805 Shares of Dr. Reddy's Laboratories Ltd $RDY

Cronos Group Inc (CRON) Institutional Confidence

This article provides details on the institutional confidence score for Cronos Group Inc. (CRON), which remains at 3.00, with no change. It lists the top institutional shareholders and their recent activity, showing significant increases in holdings by D. E. Shaw & Co., L.P. and …

Indivior PLC (INDV) Financial Health: Profitability & Balance Sheet Analysis

Indivior PLC (INDV) has a current financial score of 7.94, ranking 87th out of 155 in the Pharmaceuticals industry, indicating a weak financial status despite high operating efficiency. The company reported a 19.17% year-over-year increase in quarterly revenue to $317.00 million and a 93.48% …

Possible Generic Drug Tariffs and 2 Microcaps

This article discusses the potential impact of proposed tariffs on imported generic drugs, which could reach 100-200%, and examines two microcap companies, Elite Pharmaceuticals (ELTP) and Cumberland Pharmaceuticals (CPIX), that might be affected. ELTP, a domestic manufacturer, could benefit from competitors facing tariffs, while …

Alpha Teknova Inc (TKNO) Institutional Confidence

This article analyzes Alpha Teknova Inc.'s (TKNO) institutional confidence, noting its current score of 7.00, placing it 78th in its industry. Institutional shareholding stands at 85.48%, an increase of 2.70% quarter-over-quarter. The largest institutional shareholder is Chuck Royce, holding 1.99% of outstanding shares.

AQST|Aquestive Therapeutics Inc|Price:3.725|Chg%:+0.125

This article provides a comprehensive stock analysis of Aquestive Therapeutics Inc (AQST) by TradingKey, detailing its stock score, financial health, valuation, earnings forecast, price momentum, institutional confidence, and risk assessment. The company has healthy fundamentals, high growth potential, and its valuation is considered fairly …